Status:
COMPLETED
Cost-effectiveness of PCI With Taxus vs CABG - 5 Years FUP
Lead Sponsor:
Medical University of Vienna
Conditions:
Multivessel Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
The objective of the present study is to analyze the cost-effectiveness of percutaneous coronary intervention (PCI) using TAXUS stents compared to the costs of coronary artery bypass surgery (CABG) in...
Eligibility Criteria
Inclusion
- two or three-vessel disease requiring percutaneous or surgical multivessel intervention with the aim of complete revascularization
- age \> 18 years
- clinical symptoms (stable or unstable angina) or signs of myocardial ischemia
- ≥ 50% diameter stenosis of each lesion
Exclusion
- acute myocardial infarction (\< 48 h);
- contraindications to clopidogrel, aspirin, heparin and taxol;
- pregnancy or lack of protection against pregnancy or breast-feeding during the study;
- hemorrhagic diathesis and platelet count \<100.000/ml3
Key Trial Info
Start Date :
January 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT01199419
Start Date
January 1 2004
End Date
July 1 2014
Last Update
July 18 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna, Dept. of Cardiology
Vienna, Austria, 1090